Our Researchers
See below for details on our researchers and their area of expertise.
Prof. Chun-Xia Zhao leads the Bioinspired Materials and Devices lab (BMD), focusing on bioinspired nanomaterials for drug delivery (including polymer/lipid nanoparticles and nanocapsules for delivering small molecule drugs, peptides/proteins, and RNAs), and biomimetic devices (tumor chip, organ chip, soft electronics) for drug development.
View Prof. Chun-Xia Zhao's researcher profile
Associate Professor Branka Grubor-Bauk
Branka leads the Viral Immunology Group at the Adelaide Medical School. Her research focuses on development of novel mRNA vaccines and lipid nanoparticles in infectious diseases and cancer immunotherapy.
View Branka's researcher profile
Robert’s research aims to better understand in-vitro transcription and lipid nanoparticle assembly for mRNA and CRISPR delivery using a fusion of scientific and engineering strategies.
View Robert's researcher profile
Professor Christopher Sweeney, MBBS, FRACP, DHSc is the DirectorSAiGENCI – South Australian immunoGENomics Cancer Institute and medical oncologist with expertise in drug development and cancer biology.
View Christopher's researcher profile
Brendan is Head of the Tumour Inflammation and Immunotherapy Program at SAiGENCI, and has an interest in mRNA-mediated targeting strategies against immune system regulators in cancer.
View Brendan's researcher profile
Lukas focuses on the manufacturing, purification and analytics of mRNA and plasmid DNA.
View Lukas' researcher profile
Makutiro is a research scientist specialising in developing next-generation mRNA vaccines for infectious diseases, including HCV, SARS CoV 2, and Zika.
View Makutiro's researcher profile
Zelalem is a viral immunologist specialising in developing mRNA vaccines for viruses like SARS-CoV-2, HCV, HIV, Zika, and other flaviviruses.
View Zelalem's researcher profile
Yannan is the head of Biomaterials and Immune Engineering Laboratory at SAiGENCI. His lab leverages biomaterial engineering and nanotechnology to develop mRNA-based therapeutics for cancer immunotherapy.
View Yannan's researcher profile
Michael’s research focuses on the molecular virology and cellular interactions of positive sense RNA viruses.
View Michael's researcher profile
Prof. Sarah Vreugde is the Director of Research of the Department of Otolaryngology at the University of Adelaide. Her research focuses on the development of novel therapeutics targeting chronic relapsing infections.
View Sarah's researcher profile
Dr Jolly’s research investigates the control of human brain development by mRNA splicing and decay.
View Lachlan's researcher profile